Dr. Agarwal's Eye Hospital Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Adil Agarwal

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	5.4yrs
Participación del CEO	n/a
Permanencia media de la dirección	1.5yrs
Promedio de permanencia en la Junta Directiva	5.4yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Adil Agarwal (41 yo)

5.4yrs

Permanencia

₹300,000

Compensación

Dr. Adil Agarwal serves as Chief Executive Officer at Dr. Agarwal's Eye Hospital Limited and serves as its Whole -Time Director from 2024. Dr. Agarwal serves as Chief Executive Officer and Director at Dr A...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Amar Agarwal	Founder	30.6yrs	₹23.62m	sin datos
Athiya Agarwal	Founder & Whole Time Director	no data	₹9.20m	sin datos
Yashwanth Venkat	Interim Chief Financial Officer	less than a year	₹5.07m	sin datos
Meenakshi Jayaraman	Company Secretary & Compliance Officer	2.9yrs	₹1.60m	sin datos
Adil Agarwal	CEO & Whole -Time Director	no data	₹300.00k	sin datos
Suhasini K	Head of Human Resource	no data	sin datos	sin datos
Aman Joshi	Head of Digital Marketing	less than a year	sin datos	sin datos
Terence Leo Seqi	General Manager of Projects	no data	sin datos	sin datos

1.5yrs

Permanencia media

47yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 526783 no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Amar Agarwal	Founder	30.6yrs	₹23.62m	sin datos
Athiya Agarwal	Founder & Whole Time Director	30.5yrs	₹9.20m	sin datos
Adil Agarwal	CEO & Whole -Time Director	5.4yrs	₹300.00k	sin datos
Venkatraman Balakrishnan	Independent Director	2.4yrs	₹100.00k	sin datos
Latha Ramanathan	Independent Director	less than a year	sin datos	sin datos
Shiv Agrawal	Independent Director	no data	sin datos	sin datos

5.4yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: La junta directiva de 526783 se considera experimentada (5.4 años de antigüedad promedio).

Dr. Agarwal's Eye Hospital Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Dr. Agarwal's Eye Hospital Limited Appoints Yashwanth Venkat as Key Managerial Personnel

Dr. Agarwal's Eye Hospital Limited Appoints Aman Joshi as Head of Digital Marketing

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Cessation of Sanjay Anand as Independent Director

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Aug 26, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Latha Ramanathan as an Additional Director

Recent updates

Dr. Agarwal's Eye Hospital Limited Announces Interim Dividend for the Financial Year 2024-25, Payable on or Before November 25, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Yashwanth Venkat as Key Managerial Personnel

Dr. Agarwal's Eye Hospital Limited to Report Q2, 2025 Results on Oct 29, 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 19%

Dr. Agarwal's Eye Hospital Limited Appoints Aman Joshi as Head of Digital Marketing

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Cessation of Sanjay Anand as Independent Director

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2024

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2024

Upcoming dividend of ₹2.50 per share

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Aug 26, 2024

New minor risk - Financial position

First quarter 2025 earnings released: EPS: ₹30.02 (vs ₹24.55 in 1Q 2024)

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2025 Results on Jul 25, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Latha Ramanathan as an Additional Director

Full year 2024 earnings released: EPS: ₹98.64 (vs ₹78.55 in FY 2023)

Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Financial Year 2023-2024

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2024 Results on Jan 18, 2024

Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹10.77 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Upcoming dividend of ₹2.50 per share at 0.2% yield

Second quarter 2024 earnings released: EPS: ₹26.79 (vs ₹19.30 in 2Q 2023)

Dr. Agarwal's Eye Hospital Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before 18 November 2023

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 3 1, 2023

Upcoming dividend of ₹3.00 per share at 0.1% yield

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Sep 21, 2023

Investor sentiment improves as stock rises 22%

New minor risk - Financial position

First quarter 2024 earnings released: EPS: ₹24.55 (vs ₹19.38 in 1Q 2023)

Investor sentiment improves as stock rises 21%

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2024 Results on Aug 04, 2023

Investor sentiment improves as stock rises 26%

Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Fiscal Year 2023

Full year 2023 earnings released: EPS: ₹78.55 (vs ₹51.29 in FY 2022)

Investor sentiment improves as stock rises 25%

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: EPS: ₹10.77 (vs ₹17.34 in 3Q 2022)

Dr. Agarwal's Eye Hospital Limited to Report Nine Months, 2023 Results on Jan 21, 2023

Investor sentiment improved over the past week

Dr. Agarwal's Eye Hospital Limited to Report Q2, 2023 Results on Oct 28, 2022

Now 21% undervalued

Dr. Agarwal's Eye Hospital Limited Approves Final Dividend for Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Upcoming dividend of ₹3.00 per share

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Sep 14, 2022

First quarter 2023 earnings released: EPS: ₹19.38 (vs ₹1.54 loss in 1Q 2022)

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2023 Results on Aug 04, 2022

Full year 2022 earnings released: EPS: ₹51.29 (vs ₹3.06 loss in FY 2021)

Dr. Agarwal's Eye Hospital Limited Recommends Dividend for the Financial Year 2022

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Resignation of T.R. Ramasubramanian as Independent Director

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

TPG Reportedly in Advanced Talks to Acquire 40% in Dr Agarwal's Health Care

Investor sentiment improved over the past week

Company Secretary & Compliance Officer Jully Jivani has left the company

First quarter 2022 earnings released: ₹1.54 loss per share (vs ₹16.19 loss in 1Q 2021)

Full year 2021 earnings released: ₹3.06 loss per share (vs ₹29.11 profit in FY 2020)

New 90-day high: ₹302

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2021 Results on Jan 25, 2021

New 90-day high: ₹275

New 90-day high: ₹274

First half earnings released

Dr. Agarwal's Eye Hospital Limited to Report Q4, 2021 Results on May 30, 2021

New 90-day high - ₹266

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2021 Results on Aug 12, 2020